JBT Marel Corporation (JBTM) SEC Filings & Earnings Calls
EquiReason read 12 JBT Marel Corporation SEC filings in the last 12 months. Latest: 10-Q on 2026-08-05 — JBT Marel reported Q2 2026 revenue of $981M and net income of $28M, with a $33M impairment in Protein Solutions..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 5.6B
- P/E TTM
- 29.5
- Dividend yield
- 0.4%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
5 Aug 202610-QJBT Marel reported Q2 2026 revenue of $981M and net income of $28M, with a $33M impairment in Protein Solutions.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $981M | +5% y/y |
| Net income · Q2-2026 | $28M | +833% y/y |
| Backlog · 2026-06-30 | $1.50B |
Risks flagged
Integration risk from Marel acquisition
“The impairment charge resulted from updated business forecasts for the affected operation.”
High leverage
“Total debt, including current portion $1,679 million as of June 30, 2026.”
3 Aug 20268-K · 2.02Q2 2026 revenue $981M (+5% YoY), orders $1.03B (book-to-bill 1.05x), backlog $1.54B; adj. EBITDA margin 17.1% (+40bps); FY guidance reiterated; $200M buyback authorized.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $981M | +5% y/y |
| Net income · Q2-2026 | $28M | |
| Net income margin · Q2-2026 | 2.9% | |
| Adjusted EBITDA · Q2-2026 | $168M | |
| Adjusted EBITDA margin · Q2-2026 | 17.1% | |
| Diluted EPS · Q2-2026 | $0.54 | |
| Adjusted EPS · Q2-2026 | $1.95 | |
| Orders · Q2-2026 | $1.03B | |
| Backlog · Q2-2026 | $1.54B | |
| Operating cash flow · H1-2026 | $221M |
Guidance
FY26 revenue $3,990-$4,065M; adj. EBITDA margin 17.0%-17.5%; adj. EPS $7.85-$8.35; GAAP EPS $4.20-$4.70; net income margin 5.5%-6.0%
FY2026 revenue and adj. EBITDA margin guidance reiterated; adj. EPS refined; strong demand and record backlog support H2 outlook.
Risks flagged
Operational inefficiencies and logistics constraints in Prepared Food and Beverage Solutions segment may persist.
“we experienced some operational inefficiencies and logistics constraints in the Prepared Food and Beverage Solutions segment in the second quarter” · word for word
Higher inflationary costs create near-term headwinds.
“we are navigating a dynamic operating environment with higher inflationary costs.” · word for word
Non-cash impairment charge of $33M indicates potential overpayment for prior acquisition.
“a $33 million non-cash, non-recurring impairment charge related to a 2021 acquisition.” · word for word
6 May 202610-QRevenue $936M; Net Income $45M; Backlog $1.50Bopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $936M | |
| Net Income · Q1-2026 | $45M | |
| Backlog · 2026-03-31 | $1.50B | |
| Diluted EPS · Q1-2026 | $0.86 |
Guidance
Backlog of $1.5B provides revenue visibility; NextGen strategy targets organic growth and margin expansion; no specific numeric guidance provided.
Risks flagged
High Debt Levels from Acquisition
“Total debt, including current portion $1,843 million; $403 million convertible notes due May 2026.”
Integration Risk from Marel Acquisition
“Acquisition-related transaction costs totaling $64 million were recorded as Selling, general and administrative expense during the three months ended March 31, 2025.”
Foreign Exchange Exposure
“The Company manufactures and sells products in a number of countries throughout the world and, as a result, the Company is exposed to movements in foreign currency exchange rates.” · word for word
4 May 20268-K · 2.02Revenue $936M (+10% y/y); Orders $1.07B; Backlog $1.49B; Guidance: Revenue $3.99-$4.065B, adjusted EBITDA margin 17.0%-17.5%, adjusted EPS $8.00-$8.50earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $936M | +10% y/y |
| Orders · Q1-2026 | $1.07B | |
| Backlog · Q1-2026 | $1.49B | |
| Net income · Q1-2026 | $45M | |
| Adjusted EBITDA · Q1-2026 | $142M | |
| Adjusted EBITDA margin · Q1-2026 | 15.2% | |
| GAAP diluted EPS · Q1-2026 | $0.86 | |
| Adjusted EPS · Q1-2026 | $1.58 | |
| Operating cash flow · Q1-2026 | $119M | |
| Free cash flow · Q1-2026 | $100M |
Guidance
Revenue $3.99-$4.065B, adjusted EBITDA margin 17.0%-17.5%, adjusted EPS $8.00-$8.50
Reiterated FY2026 guidance with strong Q1 demand and margin expansion trajectory.
Risks flagged
Tariff cost pressure on Prepared Food & Beverage segment margin.
“Segment adjusted EBITDA margin declined 170 basis points, which was impacted, as expected, by higher tariff costs” · word for word
CPG end market softness affecting Prepared Food & Beverage volume.
“lower volume from the CPG end market” · word for word
Operational challenges in warehouse automation business.
“operational challenges in the warehouse automation business” · word for word
1 Apr 2026DEF 14AAnnual proxy statement filed for 2026 annual meeting, detailing executive compensation and governance.open
Figures in the filing · each found in the filing text
| Total revenue · FY2025 | $3.80B | +121% y/y |
| Income from continuing operations · FY2025 | $-50M | |
| Adjusted EBITDA from continuing operations · FY2025 | $600M | +104% y/y |
| Adjusted diluted earnings per share from net income · FY2025 | $6.41 | +4% y/y |
| Financial Leverage Ratio · FY2025 | $2.90 | |
| Adjusted EBITDA Margin · FY2025 | 15.8% |
Risks flagged
Tariff Environment Uncertainty
“all while facing a constantly evolving tariff environment” · word for word
Integration Risk
“Our integration efforts focused on the customer value proposition.” · word for word
Pension Settlement Costs
“Recognition of non-cash pension plan related settlement costs 146.9 23.3 —” · word for word
2 Mar 202610-KRecurring revenue as % of total revenue 50open
Figures in the filing · each found in the filing text
| Recurring revenue as % of total revenue · FY2025 | 50.0% |
Risks flagged
Integration Risk from Marel Acquisition
“During the fourth quarter of 2025, we realigned our reportable segments to better reflect the integration of our new operating model.” · word for word
Fixed-Price Contract Risk
“Under such contracts, we are typically responsible for cost overruns. Our actual costs and any gross profit realized on these fixed-price contracts may vary from our estimates on which the pricing for such contracts was based.” · word for word
Supply Chain and Raw Material Cost Risk
“Increases in commodity prices resulting in increased manufacturing costs, such as petroleum-based products, metals or other raw materials we use in significant quantities.” · word for word
23 Feb 20268-K · 2.02Revenue $3.80B; Adjusted EBITDA $600M; Adjusted EBITDA margin 15.8; Guidance: 2026 revenue guidance $3.99B-$4.065B; adjusted EBITDA margin 17.0%-17.5%earningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $3.80B | |
| Adjusted EBITDA · FY2025 | $600M | |
| Adjusted EBITDA margin · FY2025 | 15.8% | |
| Orders · FY2025 | $3.80B | |
| Backlog · Q4-2025 | $1.40B | |
| Free cash flow · FY2025 | $250M | |
| Operating cash flow · FY2025 | $342M | |
| Protein Solutions segment revenue · Protein Solutions · FY2025 | $1.72B | |
| Prepared Food and Beverage Solutions segment revenue · Prepared Food and Beverage Solutions · FY2025 | $2.08B | |
| Adjusted EPS · FY2025 | $6.41 |
Guidance
2026 revenue guidance $3.99B-$4.065B; adjusted EBITDA margin 17.0%-17.5%
2026 guidance reflects continued growth in revenue, margins, and earnings; synergy savings expected.
Risks flagged
Tariff environment remains a challenge; integration risks from Marel acquisition.
“challenging tariff environment... M&A related costs of $115 million”
18 Feb 20268-K · 7.01Segment Adjusted EBITDA - Protein Solutions Q1 2025 $62M; Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q1 2025 $78M; Segment Adjusted EBITDA - Protein Solutions Q2 2025 $86Mopen
Figures in the filing · each found in the filing text
| Segment Adjusted EBITDA - Protein Solutions Q1 2025 · Protein Solutions · Q1-2025 | $63M | |
| Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q1 2025 · Prepared Food and Beverage Solutions · Q1-2025 | $78M | |
| Segment Adjusted EBITDA - Protein Solutions Q2 2025 · Protein Solutions · Q2-2025 | $86M | |
| Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q2 2025 · Prepared Food and Beverage Solutions · Q2-2025 | $94M | |
| Segment Adjusted EBITDA - Protein Solutions Q3 2025 · Protein Solutions · Q3-2025 | $94M | |
| Segment Adjusted EBITDA - Prepared Food and Beverage Solutions Q3 2025 · Prepared Food and Beverage Solutions · Q3-2025 | $102M |
Risks flagged
Integration risk from Marel acquisition; restructuring costs incurred.
“Restructuring related costs of $10.6M (Q1), $5.6M (Q2), $7.4M (Q3); M&A related costs of $74.4M (Q1), $20.0M (Q2), $5.8M (Q3).”
4 Nov 202510-QQ3 2025 revenue exceeded expectations, but JBT segment margins declined due to tariffs; Marel acquisition contributed significantly.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Total · Q3-2025 | $1.00B | +121% y/y |
| Adjusted EBITDA from continuing operations · Total · Q3-2025 | $171M | +109% y/y |
| Adjusted EBITDA margin from continuing operations · Total · Q3-2025 | 17.1% | |
| JBT segment Adjusted EBITDA · JBT · Q3-2025 | $71M | -13% y/y |
| JBT segment Adjusted EBITDA margin · JBT · Q3-2025 | 15.3% | |
| Marel segment Adjusted EBITDA · Marel · Q3-2025 | $100M | |
| Marel segment Adjusted EBITDA margin · Marel · Q3-2025 | 18.6% | |
| Adjusted diluted earnings per share from continuing operations · Q3-2025 | $1.94 | +10% y/y |
| Free cash flow · 9M-2025 | $163M | +106% y/y |
Guidance
2025 capex $90M-$95M; restructuring savings target $50M-$60M; tariff impacts expected
Revenue exceeded expectations, but tariff headwinds and margin pressure acknowledged. Mitigation actions underway.
Risks flagged
Tariff cost pressure on margins
“The decrease of $10.4 million or 12.7% was primarily driven by a decrease in gross profit from tariff impacts, unfavorable mix, and project variances.” · word for word
Integration execution risk
“the inability to successfully integrate the legacy businesses of JBT and Marel, operationally, technologically, culturally or otherwise” · word for word
High leverage from Marel acquisition
“Interest expense increased $20.6 million compared to same period last year. The increase was driven by a higher average debt balance as well as higher interest rates on additional borrowings to fund the Marel Transaction” · word for word
3 Nov 20258-K · 2.02Revenue $1.00B; Orders $946M; Backlog $1.30B; Guidance: FY2025 revenue guidance raised to $3.76B-$3.79B; adjusted EBITDA margin 15.75%-16.0%; adjusted EPS $6.10-$6.40earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $1.00B | |
| Orders · Q3-2025 | $946M | |
| Backlog · Q3-2025 | $1.30B | |
| Income from Continuing Operations · Q3-2025 | $67M | |
| Adjusted EBITDA · Q3-2025 | $171M | |
| Adjusted EBITDA Margin · Q3-2025 | 17.1% | |
| Diluted EPS · Q3-2025 | $1.28 | |
| Adjusted EPS · Q3-2025 | $1.94 | |
| Operating Cash Flow (YTD) · 9M-2025 | $224M | |
| Free Cash Flow (YTD) · 9M-2025 | $163M |
Guidance
FY2025 revenue guidance raised to $3.76B-$3.79B; adjusted EBITDA margin 15.75%-16.0%; adjusted EPS $6.10-$6.40
Raised guidance on strong Q3 performance, synergy savings, and operational productivity.
Risks flagged
Restructuring and M&A costs continue; $7M restructuring and $6M M&A costs in Q3.
“third quarter 2025 ... $7 million in restructuring related costs, and $6 million in M&A related costs”
JBT Marel Corporation — questions
- What did JBT Marel Corporation file recently?
- 12 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-05 — JBT Marel reported Q2 2026 revenue of $981M and net income of $28M, with a $33M impairment in Protein Solutions.
Every figure on this page comes from JBT Marel Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.